Research project overview ALICE: A randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer REPORT: Reirradiation and PD-1 blockade on recurrent squamous cell head and neck tumors ICON: A randomized phase IIb study evaluating immunogenic chemotherapy combined with double immunological checkpoint blockade in patients with metastatic luminal B breast cancer
Valsala Kumari R, Pandya AD, Pettersen SJ, Kvalvaag A, Myrann AG, Ghiarasim R, Rotaru A, Dimofte MG, Skotland T, Sandvig K, Mari Mælandsmo G, Iversen TG (2025) Evaluation of HER2 Targeted Poly(Ethylene Glycol)-Poly(L-histidine) Copolymer Micelles in Breast Cancer Models Macromol Biosci, e00047 (in press) DOI 10.1002/mabi.202500047, PubMed 40719176 Singh R, Kyte JA (2025) STEAP1: a promising target in prostate cancer therapy Trends Cancer (in press) DOI 10.1016/j.trecan.2025.05.007, PubMed 40527692 Røssevold AH, Tekpli X, Lingjærde OC, Russnes HG, Vallon-Christersson J, Borgen E, Lømo J, Garred Ø, Dorraji E, Kristensen VN, Naume B, Kyte JA (2025) High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis Commun Med (Lond), 5 (1), 234 DOI 10.1038/s43856-025-00865-z, PubMed 40523912
